Management of endocrine disease: does gender matter in the management of acromegaly? NF Lenders, AI McCormack, KKY Ho European Journal of Endocrinology 182 (5), R67-R82, 2020 | 56 | 2020 |
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma) N Lenders, A McCormack Pituitary 21, 217-229, 2018 | 46 | 2018 |
Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas N Lenders, S Ikeuchi, AW Russell, KKY Ho, JB Prins, WJ Inder Clinical Endocrinology 84 (2), 222-228, 2016 | 41 | 2016 |
Predictors for secondary therapy after surgical resection of nonfunctioning pituitary adenomas J Ratnasingam, N Lenders, B Ong, S Boros, AW Russell, WJ Inder, ... Clinical endocrinology 87 (6), 717-724, 2017 | 23 | 2017 |
Transcription factor immunohistochemistry in the diagnosis of pituitary tumours NF Lenders, AC Wilkinson, SJ Wong, TT Shein, RJ Harvey, WJ Inder, ... European Journal of Endocrinology 184 (6), 891-901, 2021 | 21 | 2021 |
A population-level analysis of pituitary carcinoma from the national cancer database RM Carey, EC Kuan, AD Workman, NN Patel, MA Kohanski, CCL Tong, ... Journal of Neurological Surgery Part B: Skull Base 81 (02), 180-186, 2020 | 8 | 2020 |
Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass NF Lenders, JR Greenfield Endocrinology, diabetes & metabolism case reports 2019 (1), 2019 | 8 | 2019 |
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours NF Lenders, J Chui, J Low, WJ Inder, PE Earls, AI McCormack Pituitary 25 (6), 997-1003, 2022 | 7 | 2022 |
Towards precision medicine for clinically non‐functioning pituitary tumours NF Lenders, WJ Inder, AI McCormack Clinical Endocrinology 95 (3), 398-409, 2021 | 6 | 2021 |
Pituitary tumours: molecular and genetic aspects SMC De Sousa, NF Lenders, LS Lamb, WJ Inder, A McCormack Journal of Endocrinology 257 (3), 2023 | 5 | 2023 |
The evolution in pituitary tumour classification: a clinical perspective NF Lenders, PE Earls, WJ Inder, AI McCormack Endocrine Oncology 3 (1), 2023 | 4 | 2023 |
Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres NF Lenders, PE Earls, AC Wilkinson, M Costin, M Hofer, TT Shein, ... European Journal of Endocrinology 189 (1), 106-114, 2023 | 3 | 2023 |
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2 NF Lenders, TJ Thompson, J Chui, J Low, WJ Inder, PE Earls, ... Pituitary, 1-11, 2024 | | 2024 |
Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors NF Lenders, AC Wilkinson, SJ Wong, TT Shein, RJ Harvey, WJ Inder, ... Journal of the Endocrine Society 5 (Suppl 1), A651, 2021 | | 2021 |
Rapidly expanding Prolactinoma N Lenders, D McLeod Clinical Endocrinology 89 (Supplement 1), 92-92, 2018 | | 2018 |
H. pylori on guard to prevent obesity and overweight? N Lenders, G Holtmann JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26, 86-86, 2011 | | 2011 |
Is the decrease of H. pylori associated with endemic obesity in the western world? NF Lenders, G Holtmann Journal of Gastroenterology and Hepatology 26, 78-78, 2011 | | 2011 |